The May / June 2021 issue of Clinical OMICs features a four-page interview with Congenica CEO David Atkins, who talks about the genomic medicine landscape and Congenica's plans for the future.
In this in-depth article, Chris Anderson, Editor in Chief at Clinical OMICs, speak to David about:
- Significant developments at Congenica and lessons learned
- The growth and outsourcing of sequencing capabilities
- What Congenica's $50 million financing round means for the business
- New developments from Congenica, including cancer offering
- New partnership with Sanford Health
- Integrating genomic data into mainstream healthcare
To read the article in full, please visit ClinicalOMICS
